Scientists have discovered a new “mastermind fusion gene” may be associated with a rare cancer-causing tumor — pheochromocytomas (“pheo”) and paragangliomas — according to a study. This breakthrough discovery could lead to more precise treatment as well as a better understanding of cancer itself.